PATENT CLAIM ANALYSIS

Application Number: 16300301
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-04
Patent Classification: ["544", "363000"]

Abstract:
Disclosed are a crystal form of brexpiprazole and a preparation method therefor. The X-ray powder diffraction pattern, which is detected with Cu—Kα radiation, of the crystal form of brexpiprazole has characteristic peaks at the positions where 2θ is about 9.1±0.2, 15.2±0.2, 15.7±0.2, 17.6±0.2, 18.1±0.2, 24.4±0.2. The crystal form I of brexpiprazole has a high purity, good stability and good reproducibility, and is suitable for industrial production.

Claim (Index 1):
A crystal form I of brexpiprazole having a structure of formula I, wherein an X-ray powder diffraction pattern of the crystal form I comprises characteristic peaks of 9.1\u00b10.2, 15.2\u00b10.2, 15.7\u00b10.2, 17.6\u00b10.2, 18.1\u00b10.2, 18.6\u00b10.2, 24.4\u00b10.2 degrees 2\u03b8,

Metadata:
- Claim Count in Document: 7.0
- Percentile: 98.0
- Lexical Diversity: 1.59184
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16066402', '15294644', '14396224', '16065880', '16065884']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.775863415327079
- 35 USC 102 Novelty (BERT): 0.4861473843360688
- Combined Prediction Score: 0.746891812227978
- Mean Citation Score: 217.711684
- Max Citation Score: 247.41145
- Similarity Product: 208.3176556288689

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test